Close
  Indian J Med Microbiol
 

Figure 3: Inhibitory effects of antroquinonol (Antroq) on proliferation of smooth muscle cells (SMCs). The percentages of proliferation in different doses of Antroq (0.1, 0.3, or 3.0 μg/mL) treatment before primed with or without platelet-derived growth factor (10 ng/mL) in SMCs. ***P < 0.005. n = 3 each time, triplicated. Analysis of variance method with least significant difference post-hoc were used

Figure 3: Inhibitory effects of antroquinonol (Antroq) on proliferation of smooth muscle cells (SMCs). The percentages of proliferation in different doses of Antroq (0.1, 0.3, or 3.0 μg/mL) treatment before primed with or without platelet-derived growth factor (10 ng/mL) in SMCs. ***<i>P</i> < 0.005. <i>n</i> = 3 each time, triplicated. Analysis of variance method with least significant difference <i>post-hoc</i> were used